Corcept Therapeutics CEO Joseph Belanoff's 2018 pay jumps 48% to $6.3M
Corcept Therapeutics reports 2018 executive compensation
By ExecPay News
Published: April 24, 2019
Corcept Therapeutics reported fiscal year 2018 executive compensation information on April 24, 2019.
In 2018, five executives at Corcept Therapeutics received on average a compensation package of $3.4M, a 46% increase compared to previous year.
Average pay of disclosed executives at Corcept Therapeutics
Joseph K. Belanoff, Chief Executive Officer, received $6.3M in total, which increased by 48% compared to 2017. 82% of Belanoff's compensation, or $5.2M, was in option awards. Belanoff also received $478K in bonus and $680K in salary.
G. Charles Robb, Chief Financial Officer, received a compensation package of $2.8M, which increased by 60% compared to previous year. 76% of the compensation package, or $2.2M, was in option awards.
Charles Robb, Chief Financial Officer, earned $2.8M in 2018, a 60% increase compared to previous year.
Sean Maduck, Senior Vice President, Commercial, received $2.8M in 2018, which increases by 2% compared to 2017.
Robert S. Fishman, Chief Medical Officer, earned $2.3M in 2018, a 101% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 24, 2019.